Dr. Andrei Horia Iagaru, MD

Dr. Iagaru practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Iagaru's NPI, 1750404752, was assigned on April 6, 2007. Dr. Iagaru graduated from Carol Davila University of Medicine and Pharmacy in 2000. Dr. Iagaru's California license number on file is A92375.

Dr. Iagaru's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Iagaru's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Iagaru is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Iagaru to 1 more hospital and 1 medical group, each named with a free account. Dr. Iagaru's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iagaru practices, 3 sites in all. Vendor and product names are available with a free account.

Nuclear radiology is Dr. Iagaru's primary specialty in the NPI Registry, under taxonomy code 2085N0904X. Dr. Iagaru is board certified in nuclear medicine by the American Board of Nuclear Medicine. Dmand AI has Dr. Iagaru's licenses on file in 2 states: California and Pennsylvania.

CMS data shows 835 Medicare services from Dr. Iagaru across 10 procedure codes in 2024, for 898 Medicare patients. Medicare paid $39,767 for them.

CMS counts 898 Medicare patients who saw Dr. Iagaru in 2024. The largest group is 65 to 74, with 404 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iagaru's median patient age at 61, with 65% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Iagaru for performance year 2024, reported as part of a group. Dr. Iagaru accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 248 papers to Dr. Iagaru, published from 2005 to 2025. 2019 was the busiest year, with 21. The most frequent topics are Positron-Emission Tomography, Radiopharmaceuticals and Fluorodeoxyglucose F18. Dr. Iagaru has published most often in J Nucl Med. Dr. Iagaru's most frequent co-authors are Farshad Moradi, MD, PhD, Guido Alejandro Davidzon, MD, MS and Erik Supratik Mittra, MD, PhD.

Dmand AI links Dr. Iagaru to 18 clinical trials, 6 of them phase 2 studies. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Amyloid Neuropathies. Andrei Iagaru sponsors the most, 8. Open Payments lists research payments to Dr. Iagaru that name 1 trial.

CMS Open Payments shows 130 general payments to Dr. Iagaru from 12 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 60% of the total. GE Healthcare paid the most, $92,294. It also lists 5 research payments totaling $1,809 from 2020 to 2025, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Iagaru, most recently CMS Stage 1 EHR in 2011.

Dr. Iagaru graduated from Carol Davila University of Medicine and Pharmacy in 2000.

Dr. Iagaru is in network with 7 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.